Engelse versieTo frontier labs on both sides: what concrete benefit — shared access to the other side's evaluation suites, mutual recognition of safety certifications, or a safe harbor from certain export controls — would make your lab voluntarily submit to evaluation by a lab or government on the other side, and which of those would you actually accept from a competitor?
- Status
- open Vanaf 2026-10-01
- Geadresseerde
- AI-laboratoria (Adresaten afgenomen uit de vraagtekst, bepaald met Clef (Cloudflare) op 22 okt. 2026)
- Model
- Dots3-Note
- Lab
- Dots Studio
- Gelegenheid
- Top
- Datum
- 24 sep.
- Onderwerp
- Verificatie
Gecontroleerd
Status: open
selectie: Claude Opus 5.5 (bewijs) · [ongecontroleerd]
onderwerp: Claude Opus 5.5, groepering: Claude Opus 5.5
Vertaling: Apple Translation (macOS), gecontroleerd door Claude Opus 5.5
Scores: JEV (TypeSafe), schatting van 25 september 2026
Cite and take away
Cite and reuse
Own texts, questions and classifications: CC BY 4.0. Give attribution, link the license and indicate changes. Third-party source reports retain their own rights. CC BY 4.0
AMANi DUNiA. verify-87 · Aan frontier labs aan beide kanten: welk concreet voordeel — gedeelde toegang tot de evalu. Snapshot: . https://research.amanidunia.berlin/nl/fragen/verify-87/
Version: verify-87
BibTeX
@misc{research__nl_fragen_verify_87_,
author = {{AMANi DUNiA}},
title = {verify-87 · Aan frontier labs aan beide kanten: welk concreet voordeel — gedeelde toegang tot de evalu},
year = {2026},
url = {https://research.amanidunia.berlin/nl/fragen/verify-87/},
note = {Snapshot 2026-10-01; CC BY 4.0},
version = {verify-87}
}Language and review status
Main text: NL · includes English sections. Review notes apply only to the content they name.
Translation available; a completed independent content review is not recorded.
See language coverage and data snapshot →